WALTHAM, Mass.--(BUSINESS WIRE)--Naveris, Inc., the leader in precision oncology diagnostics for viral-related cancers, today announced that the Centers for Medicare & Medicaid Services (CMS) has ...

Based on component, the software segment dominated the market with the largest revenue share of 46.2% in 2025. The segment growth is driven by continuous advancements in AI algorithms, increasing ...

Most of today's clinical diagnostic tools are designed to detect the presence of a specific and known pathogen. These targeted assays—like the PCR and antigen tests that have become widely used during ...

Healthcare providers have better treatment options and can make better, evidence-based treatment decisions because of ...

Drivers can now no longer simply pop the hood to work on their cars. Understanding automotive technology is equally important as understanding mechanics. Whether you're an enthusiast or a professional ...

Leica Biosystems, a global leader in anatomic pathology solutions and workflow automation, and Advanced Cell Diagnostics, Inc. (ACD), a world leader in RNA biomarker analysis for precision medicine, ...

For most of the 20th century all women with breast cancer received similar treatment. Therapy has since become more individualized: breast cancers are now divided into subtypes and treated accordingly ...

Bio-Techne, which makes proteins for biomedical and clinical researchers, will acquire Advanced Cell Diagnostics for $250 million in cash, with a potential $75 ...

Space utilisation: Efficient use of existing infrastructure, such as public healthcare facilities, can reduce operational costs and improve access, especially in rural areas. Subsidised utilities: ...